Oncology Grand Rounds Series: Part 4 — Lymphomas and Chronic Lymphocytic Leukemia

Oncology Grand Rounds Series: Part 4 — Lymphomas and Chronic Lymphocytic Leukemia
A satellite symposium held at the 2017 ONS Annual Congress

Oncology Grand Rounds Series:
Part 4 — Lymphomas and Chronic Lymphocytic Leukemia

01:58 minutes | 2.2 Contact hours.

Video proceedings from the fourth in a series of 7 integrated symposia held at the 2017 ONS Annual Congress. Featuring perspectives from Dr Ann S LaCasce, Ms Kim Leake, Ms Mollie Moran and Dr Michael E Williams.

To complete the Post-test and Educational Assessment and Credit Form, click here. A statement of CNE credit will be issued for scores of 80% or better. Your statement of credit will be mailed to you within 3 weeks or may be printed online.

Related links:

Introduction
74-year-old man with chronic lymphocytic leukemia (CLL) and mild disease progression less than 6 months after completion of obinutuzumab/chlorambucil therapy
57-year-old woman with del(17p) and trisomy 12 CLL who is concerned about missing work because of venetoclax treatment
61-year-old woman with Grade I follicular lymphoma who is in complete response with no residual side effects from 2 years of rituximab therapy
45-year-old woman with Stage IV classical Hodgkin lymphoma (cHL) and a multitude of ongoing psychosocial issues
64-year-old man with Stage III cHL who was in the process of retiring and moving south with his wife when he received his diagnosis
73-year-old man with Stage IV mantle cell lymphoma who enrolled on a clinical trial of ibrutinib with no tolerance issues
54-year-old patient with Stage IVB diffuse large B-cell lymphoma (GCB subtype) and extranodal involvement
Review additonal nursing video education programs:
Non-Small Cell Lung Cancer
2.2 Contact hours
Cancer Immunotherapy
1.6 Contact hours
Breast Cancer
1.6 Contact hours
Myeloproliferative Neoplasms
1.6 Contact hours
Ovarian Cancer
1.75 Contact hours
Gastrointestinal Cancers
2.1 Contact hours